Ra Capital Management, Director: Artiva Biotherapeutics ARTV Buy · Filed 06/29

Trade details

Type: Insider buy
Amount: $275,280
Shares · price: 31,000 sh · $8.88 a share
Held after: 16,794,043 sh
Stock: Artiva Biotherapeutics ARTV
Person: Ra Capital ManagementDirector
Trade date: 26/06/25
Filed: 26/06/29
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 6 insiders
Holding change: +0.2%

Artiva Biotherapeutics trades, last 26 weeks

What else happened in Artiva Biotherapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Ra Capital Management's recent trades

Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16
Ra Capital Management10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$153K
6,146 sh
$153K
Filed 06/17
Traded 06/15

Ra Capital Management, Director — bought $275.3K of Artiva Biotherapeutics ARTV · 31,000 sh @ $8.88 | Whalegun